Stroke associated with surgical and transcatheter treatment of aortic stenosis

A comprehensive review

Benoit Daneault, Ajay J. Kirtane, Susheel K. Kodali, Mathew R. Williams, Philippe Genereux, George R. Reiss, Craig R. Smith, Jeffrey W. Moses, Martin B. Leon

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Stroke is a potential complication of treating patients with aortic stenosis via surgical aortic valve replacement (AVR), transcatheter aortic valve replacement (TAVR), and balloon aortic valvuloplasty. Because there are limited and heterogeneous data on the incidence, risk factors, and outcomes of stroke among patients being treated for aortic stenosis, we performed a comprehensive review of the literature. The risk of stroke after AVR in the general population is approximately 1.5%, and the risk is increased (to approximately 2% to 4%) in older and higher-risk patients. Strokes were reported in 1.5% to 6% of patients treated with TAVR, and in the only randomized trial of AVR versus TAVR, there was an increased risk of 30-day strokes (minor and major strokes and transient ischemic attacks) with TAVR (5.5% vs. 2.4%, p = 0.04).

Original languageEnglish (US)
Pages (from-to)2143-2150
Number of pages8
JournalJournal of the American College of Cardiology
Volume58
Issue number21
DOIs
StatePublished - Nov 15 2011
Externally publishedYes

Fingerprint

Aortic Valve Stenosis
Stroke
Aortic Valve
Therapeutics
Balloon Valvuloplasty
Transient Ischemic Attack
Surgical Instruments
Transcatheter Aortic Valve Replacement
Incidence
Population

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Daneault, Benoit ; Kirtane, Ajay J. ; Kodali, Susheel K. ; Williams, Mathew R. ; Genereux, Philippe ; Reiss, George R. ; Smith, Craig R. ; Moses, Jeffrey W. ; Leon, Martin B. / Stroke associated with surgical and transcatheter treatment of aortic stenosis : A comprehensive review. In: Journal of the American College of Cardiology. 2011 ; Vol. 58, No. 21. pp. 2143-2150.
@article{7c3746ecf6004e41bd0bcd10844e799d,
title = "Stroke associated with surgical and transcatheter treatment of aortic stenosis: A comprehensive review",
abstract = "Stroke is a potential complication of treating patients with aortic stenosis via surgical aortic valve replacement (AVR), transcatheter aortic valve replacement (TAVR), and balloon aortic valvuloplasty. Because there are limited and heterogeneous data on the incidence, risk factors, and outcomes of stroke among patients being treated for aortic stenosis, we performed a comprehensive review of the literature. The risk of stroke after AVR in the general population is approximately 1.5{\%}, and the risk is increased (to approximately 2{\%} to 4{\%}) in older and higher-risk patients. Strokes were reported in 1.5{\%} to 6{\%} of patients treated with TAVR, and in the only randomized trial of AVR versus TAVR, there was an increased risk of 30-day strokes (minor and major strokes and transient ischemic attacks) with TAVR (5.5{\%} vs. 2.4{\%}, p = 0.04).",
author = "Benoit Daneault and Kirtane, {Ajay J.} and Kodali, {Susheel K.} and Williams, {Mathew R.} and Philippe Genereux and Reiss, {George R.} and Smith, {Craig R.} and Moses, {Jeffrey W.} and Leon, {Martin B.}",
year = "2011",
month = "11",
day = "15",
doi = "10.1016/j.jacc.2011.08.024",
language = "English (US)",
volume = "58",
pages = "2143--2150",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "21",

}

Daneault, B, Kirtane, AJ, Kodali, SK, Williams, MR, Genereux, P, Reiss, GR, Smith, CR, Moses, JW & Leon, MB 2011, 'Stroke associated with surgical and transcatheter treatment of aortic stenosis: A comprehensive review', Journal of the American College of Cardiology, vol. 58, no. 21, pp. 2143-2150. https://doi.org/10.1016/j.jacc.2011.08.024

Stroke associated with surgical and transcatheter treatment of aortic stenosis : A comprehensive review. / Daneault, Benoit; Kirtane, Ajay J.; Kodali, Susheel K.; Williams, Mathew R.; Genereux, Philippe; Reiss, George R.; Smith, Craig R.; Moses, Jeffrey W.; Leon, Martin B.

In: Journal of the American College of Cardiology, Vol. 58, No. 21, 15.11.2011, p. 2143-2150.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Stroke associated with surgical and transcatheter treatment of aortic stenosis

T2 - A comprehensive review

AU - Daneault, Benoit

AU - Kirtane, Ajay J.

AU - Kodali, Susheel K.

AU - Williams, Mathew R.

AU - Genereux, Philippe

AU - Reiss, George R.

AU - Smith, Craig R.

AU - Moses, Jeffrey W.

AU - Leon, Martin B.

PY - 2011/11/15

Y1 - 2011/11/15

N2 - Stroke is a potential complication of treating patients with aortic stenosis via surgical aortic valve replacement (AVR), transcatheter aortic valve replacement (TAVR), and balloon aortic valvuloplasty. Because there are limited and heterogeneous data on the incidence, risk factors, and outcomes of stroke among patients being treated for aortic stenosis, we performed a comprehensive review of the literature. The risk of stroke after AVR in the general population is approximately 1.5%, and the risk is increased (to approximately 2% to 4%) in older and higher-risk patients. Strokes were reported in 1.5% to 6% of patients treated with TAVR, and in the only randomized trial of AVR versus TAVR, there was an increased risk of 30-day strokes (minor and major strokes and transient ischemic attacks) with TAVR (5.5% vs. 2.4%, p = 0.04).

AB - Stroke is a potential complication of treating patients with aortic stenosis via surgical aortic valve replacement (AVR), transcatheter aortic valve replacement (TAVR), and balloon aortic valvuloplasty. Because there are limited and heterogeneous data on the incidence, risk factors, and outcomes of stroke among patients being treated for aortic stenosis, we performed a comprehensive review of the literature. The risk of stroke after AVR in the general population is approximately 1.5%, and the risk is increased (to approximately 2% to 4%) in older and higher-risk patients. Strokes were reported in 1.5% to 6% of patients treated with TAVR, and in the only randomized trial of AVR versus TAVR, there was an increased risk of 30-day strokes (minor and major strokes and transient ischemic attacks) with TAVR (5.5% vs. 2.4%, p = 0.04).

UR - http://www.scopus.com/inward/record.url?scp=80855156727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855156727&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2011.08.024

DO - 10.1016/j.jacc.2011.08.024

M3 - Article

VL - 58

SP - 2143

EP - 2150

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 21

ER -